Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
EMDF filed an attorney letter this past week on OTC Markets; still not much volume.
EMDF not much volume in a while. Has updated filings on OTC Markets recently through year ended 12/31/22, though, and share structure is TA verified.
$BIEL BioElectronics Clinical Studies: Postoperative Pain & Edema
Postoperative Pain
Pulsed Electromagnetic Fields for Postsurgical Pain Management in Women Undergoing Cesarean Section: A Randomized, Double-Blind, Placebo-controlled Trial Results: Postoperative pain VAS scores were significantly lower in
the active-PEMF group in all the measured periods within the early
and the late postoperative periods. Fewer women in the active-
PEMF group experienced severe postoperative pain within 24
hours postoperatively (36% vs. 72%, P=0.002). Analgesic use
during the first 24 hours after C-section was 1.9-times lower in the
active-PEMF group (1.6±0.7 vs. 3.1±1.2, P<0.001). The total
analgesic use during the seventh postoperative days was 2.1-times
lower in the active-PEMF group than in the sham group (1.7±0.7
vs. 3.7±1.1, P<0.001). Seven days postoperatively, patients in
the active-PEMF group had better wound healing with no exudate,
erythema, or edema (P=0.02).
ZZLL is an undiscovered gem. They started an energy related business in China in 2020 from nothing. It is now producing $78 million in revenue. 1640% revenue growth last year. They are slightly profitable, have nearly .10 a share in cash, trading at .30 currently. Only 2 million in the float. Fully reporting. They rarely issue press releases, so no one know about them. Market cap is $6 million. Even a 1/2 of sales valuation would put them at around $2 a share. I am hoping that eventually the market discovers it, or someone buys them out.
$These 2 otc stocks will.make people multi millionaires, under a penny now, target price is $1.00 Yes a Dollar ?? BUY - $WTII AND - $PHIL SOON WILL HIT 1 DOLLAR ?? LOTS OF MONEY ?? TO BE MADE WITH THESE 2 LUCKY PENNY STOCKS THEN GO TO: PENNYSTOCKHOTPICKS.COM FOR more Hot ?? picks #BUY #PHIL & #WTII
BioElectronics adds two additional distribution partners $BIEL
https://seekingalpha.com/news/3806798-bioelectronics-adds-two-additional-distribution-partners
This is probably the most unheard stock I have ever seen but has such great potential. Do let me know what you think about it
MBH Website
https://www.mbhcorporation.com/
MBH 1H Financial Report Stats:
MBH Corporation (OTCQX:MBHCF): 1H net profit after tax of £1.9M.
Revenue of £49.6M (+81.0% Y/Y)
EBIT increased by 271% to £3.0M vs. £0.8M a year ago.
LINK: https://irp.cdn-website.com/3d13dbd6/files/uploaded/H12021%20unaudited%20financial%20statements%2030%20June21.pdf
MBH Analysis (Pros and Cons)
MBHCF is a holding company which began in 2016 that is actively building a portfolio of profitable, earnings accretive, debt-free small to medium enterprises (SME) that are expected to have a higher-than-normal growth profile as part of a larger organization. The company's operating model leaves management of the acquired companies to operate autonomously and fully accountable to develop and grow their businesses.
Strong financials
The 1H21 report has shown 81% increase in revenue and 271% increase in EBIT. These are great signs about the profitability of this company. Alongside this, the company has a strong and competitive P/e ratio of 8. P/b ratio is also healthy at about 0.3. They have produced surprisingly promising numbers despite the hit taken from Covid-19.
Dividends
The company ended the year in profit despite being heavily disrupted by the Covid-19 virus. The dividend is paid out at $0.0059 per share, which is about 2% of the current share price.
Acquisitions
The company has completed a total of 26 acquisitions so far, with 12 acquisitions in 2020 alone. The rate at which MBH is acquiring companies is impressive, and the acquired companies have very high profitability. MBH has announced on 19 August 2021 that it agreed to the terms for the acquisition of Vista Care Solutions Limited (Vista Care) as the latest step in its extensive acquisition drive. This is the 26th company in Group portfolio and it will be part of MBH's health vertical.
Bullish estimates
Analysts suggest that it could have a price target of $10 based on its financials and projected estimates, resulting in an upside of over 3000%. This price target was reiterated and maintained after the impressive 1H financial report.
Here’s a link to the analyst report:
http://www.hillsresearch.com/wp-content/uploads/2021/10/MBH-1H21.pdf
However, there are still things to consider when looking into such a stock. Here are some things I’m thinking about.
Dilution of shares
The total number of shares outstanding amounted to 70.5M at the end of 2020, up from 39.2M at the end of 2019. Dilution of shares is always a concern as it lowers the EPS. However, it is important to note that the extra shares were issued as payment to acquire companies, so this could very well be a strategic move if these acquisitions generate sufficient profit for MBH. Future profits could also be used to buy back shares to improve EPS. It was announced recently that the company CEO has also just bought back 200000 shares, and has stated that Board members are not allowed to sell any shares. This seems to be a move in the right direction.
Uncertainty about post-Covid situation
We all know how disruptive the Covid-19 situation is, especially to small businesses. It’s not certain if all companies are able to bounce back and operate at their full potential. As such, being an acquisition company, MBH is open to the risk of underperforming if their acquired companies face difficulty in recovering from the situation.
Low volume
The volume can be concerning, as there isn't much coverage for this company and this has resulted in a relatively low trading volume. In the best case, we'll see trading volume pick up as retail and institutional investors come in.
In conclusion, micro-caps are often risky. Whether you enter a position in this stock or not depends on how much you believe in the expansion model and future profitability of MBH.
MBH ESG Rating
MBH Corporation has won five stars for their ESG credentials, getting into the top 1% of the nearly 2,000 businesses in the Support the Goals database. They have achieved this level of commitment through their work with inequality and climate goals. Support the Goals encourages businesses to take responsibility and the organisation expects companies 'to demonstrate how you support the world’s most important action plan'.
This is probably the most unheard stock I have ever seen but has such great potential. Do let me know what you think about it
MBH Website
https://www.mbhcorporation.com/
MBH 1H Financial Report Stats:
MBH Corporation (OTCQX:MBHCF): 1H net profit after tax of £1.9M.
Revenue of £49.6M (+81.0% Y/Y)
EBIT increased by 271% to £3.0M vs. £0.8M a year ago.
LINK: https://irp.cdn-website.com/3d13dbd6/files/uploaded/H12021%20unaudited%20financial%20statements%2030%20June21.pdf
MBH Analysis (Pros and Cons)
MBHCF is a holding company which began in 2016 that is actively building a portfolio of profitable, earnings accretive, debt-free small to medium enterprises (SME) that are expected to have a higher-than-normal growth profile as part of a larger organization. The company's operating model leaves management of the acquired companies to operate autonomously and fully accountable to develop and grow their businesses.
Strong financials
The 1H21 report has shown 81% increase in revenue and 271% increase in EBIT. These are great signs about the profitability of this company. Alongside this, the company has a strong and competitive P/e ratio of 8. P/b ratio is also healthy at about 0.3. They have produced surprisingly promising numbers despite the hit taken from Covid-19.
Dividends
The company ended the year in profit despite being heavily disrupted by the Covid-19 virus. The dividend is paid out at $0.0059 per share, which is about 2% of the current share price.
Acquisitions
The company has completed a total of 26 acquisitions so far, with 12 acquisitions in 2020 alone. The rate at which MBH is acquiring companies is impressive, and the acquired companies have very high profitability. MBH has announced on 19 August 2021 that it agreed to the terms for the acquisition of Vista Care Solutions Limited (Vista Care) as the latest step in its extensive acquisition drive. This is the 26th company in Group portfolio and it will be part of MBH's health vertical.
Bullish estimates
Analysts suggest that it could have a price target of $10 based on its financials and projected estimates, resulting in an upside of over 3000%. This price target was reiterated and maintained after the impressive 1H financial report.
Here’s a link to the analyst report:
http://www.hillsresearch.com/wp-content/uploads/2021/10/MBH-1H21.pdf
However, there are still things to consider when looking into such a stock. Here are some things I’m thinking about.
Dilution of shares
The total number of shares outstanding amounted to 70.5M at the end of 2020, up from 39.2M at the end of 2019. Dilution of shares is always a concern as it lowers the EPS. However, it is important to note that the extra shares were issued as payment to acquire companies, so this could very well be a strategic move if these acquisitions generate sufficient profit for MBH. Future profits could also be used to buy back shares to improve EPS. It was announced recently that the company CEO has also just bought back 200000 shares, and has stated that Board members are not allowed to sell any shares. This seems to be a move in the right direction.
Uncertainty about post-Covid situation
We all know how disruptive the Covid-19 situation is, especially to small businesses. It’s not certain if all companies are able to bounce back and operate at their full potential. As such, being an acquisition company, MBH is open to the risk of underperforming if their acquired companies face difficulty in recovering from the situation.
Low volume
The volume can be concerning, as there isn't much coverage for this company and this has resulted in a relatively low trading volume. In the best case, we'll see trading volume pick up as retail and institutional investors come in.
In conclusion, micro-caps are often risky. Whether you enter a position in this stock or not depends on how much you believe in the expansion model and future profitability of MBH.
MBH ESG Rating
MBH Corporation has won five stars for their ESG credentials, getting into the top 1% of the nearly 2,000 businesses in the Support the Goals database. They have achieved this level of commitment through their work with inequality and climate goals. Support the Goals encourages businesses to take responsibility and the organisation expects companies 'to demonstrate how you support the world’s most important action plan'.
WRR.V gold expo in NV
They have drilled some hot holes and the latest campaign saw them targeting the meat of their deposit. This was in development of a 43-101 compliant resource est. Visible gold was found in at least 2 samples of their 14 holes and folks are expecting some hot ground to be uncovered.
Huge potential with a $7m market cap. 10x longer term
$IVDN: Groundbreaking Advancement in Energy Saving Insulation for the Home Building Markets Plus Unmatched Performance for Winter Clothing: Innovative Designs, Inc. (OTCQB: IVDN)
Click here:
https://www.wicz.com/story/45421148/groundbreaking-advancement-in-energy-saving-insulation-for-the-home-building-markets-plus-unmatched-performance-for-winter-clothing-innovative-designs-inc-otcqb-ivdn
$CYCA Video - Why chose IGAN for Police and Fire ground ops.
Click here:
Singular in its Genius: The POET Optical Interposer
$antman thanks; The Reason Behind China Dumping The Dollar For Physical
Gold & Silver Is This!! - Alasdair Macleod
2,970 views•Jun 7, 2021
$ACGX has a successful business in the vital packaging industry that is delivering solid growth as shown in the latest report:
Alliance Creative Group (ACGX) Reports Total Revenue of $2,613,997 for First Quarter of 2021 with Net Income of $256,799
2021 Quarterly Net Income increased by $237,206 compared to Q1 2020
CHICAGO, May 14, 2021 /PRNewswire/ -- Alliance Creative Group, Inc., (http://www.AllianceCreativeGroup.com) (Stock Symbol OTC: ACGX) is pleased to announce the results of Operations for the Three Months Ending March 31, 2021.
Revenues for the quarter ending March 31, 2021 ("Q1 2021") were $2,613,997
Gross Profits for the quarter ending March 31, 2021 ("Q1 2021") were $550,944
Net Income for the quarter ending March 31, 2021 ("Q1 2021") were $256,799
The total assets on the Balance Sheet for the Alliance Creative Group as of 3/31/21 were $3,587,857.
The total outstanding common shares as of March 31, 2021 ("Q1 2021") were 1,639,611 with 1,149,023 of those shares in the float.
The Company ended the quarter and year with ($7,257) Cash on hand.
Total Stockholder Equity as of 03/31/21 was $1,532,890
The full financial statement, balance sheet, statement of operations, cash flow statement, and disclosure statements are posted on the OTC Market Company website at www.OTCmarkets.com under the stock symbol ACGX in the section for filings and disclosure and on www.ACGX.us in the investor relations section.
Steve St. Louis, CEO of the Alliance Creative Group, Inc., said, "The first Quarter of 2021 ended with our largest Net Income in a long time, mostly due to the PPP forgiveness, but we were able to pay down more liabilities to get us in a stronger position for the future. We will continue to evaluate all our options and ideas to hopefully maintain and improve the positive progress for 2021 and beyond."
About Alliance Creative Group, Inc.
Alliance Creative Group, Inc. (Stock Symbol: ACGX) is a Packaging Solutions Company focused on Retail Packaging and Packaging Management. ACG helps its clients from initial concept and packaging development through final production and managed inventory solutions. The core business has been around since 1997. ACG currently focuses mostly on providing solutions for flexible and clear packaging, folding cartons, vendor managed inventory supply chain services and fulfillment. Additional services include but are not limited to corrugated boxes, commercial printing, labels, and other products and services related to the printing or packaging of consumer products. ACG's team includes experts to provide high-quality packaging and printed products. The ACG experience includes very hands-on operational support out of 6 different warehouse locations and several national and international manufacturing partners. ACG provides customer support during the entire product process or cycle including but not limited to creating, warehousing, delivering, and replenishing their packaging products For more information, visit http://www.AllianceCreativeGroup.com or http://www.ACGX.us.
About PeopleVine
PeopleVine is a consolidated platform that allows businesses to build more personal relationships with their customers at scale. PeopleVine solves the problem businesses have creating and managing holistic relationships with their customers without using multiple products that only support a portion of the relationship building activities. PeopleVine seamlessly brings together the tools needed to market, sell, and operate a business with streamline efficiencies in a customer engagement suite and enables businesses to make data informed decisions to help generate revenue growth.
We are committed to being the most essential and adaptive SaaS engagement platform for companies that take a customer centric approach to business.
For more information www.PeopleVine.com
This news release contains forward-looking statements as defined by the bespeaks-caution doctrine. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks described in statements filed from time to time with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the Company, are expressly qualified by the cautionary statements that may accompany the forward-looking statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
Investor Relations and Media Contact
1-847-885-1800
Info@ACGemail.com
Cision View original content:http://www.prnewswire.com/news-releases/alliance-creative-group-acgx-reports-total-revenue-of-2-613-997-for-first-quarter-of-2021-with-net-income-of-256-799--301291364.html
SOURCE Alliance Creative Group, Inc.
$CURR - Quadruple Revenue being reported for the CURR Q1 period looks very good. The company is clearly on a successful track with its multiple business lines and headed to more growth to come.
CURE Pharmaceutical First Quarter Revenue Quadruples to $1.5 million; Company Expands Clinical Pipeline to Include Psychedelics
Press Release | 05/17/2021
CURE Pharmaceutical Holding Corp. (OTC: CURR), a vertically integrated drug delivery and product development company, reported its financial results and provided an operational update for the first quarter ended March 31, 2021.
First Quarter 2021 and subsequent weeks highlights:
Total revenue rose more than 400% to $1.5 million compared with a year ago and gross profit rose in line with revenue growth.
Received approval for an Investigational New Drug (IND) application from the U.S. Food and Drug Administration and initiated clinical trials for CUREfilm Blue™, an oral soluble film of sildenafil citrate to treat erectile dysfunction.
Commenced clinical development of novel delivery vehicles for certain psychedelic compounds including psilocybin, LSD, and MDMA, which are known to treat a variety of mental health disorders.
Through its Sera Labs subsidiary, launched a new line of Nutri-Strips™ vitamins and supplements that utilize CURE’s proprietary technology, and which are being sold direct to consumer, including via Amazon.
Subsequent to quarter’s end, on May 6, 2021 received a $2.3 million payment related to a contract dispute that was resolved in April.
“During the first quarter, we made good headway on a number of important fronts,” said Rob Davidson, CURE Pharmaceutical CEO. “We advanced the clinical development of two of our newest programs, one for an antiviral active pharmaceutical ingredient (API) in which we will apply our patented CUREfilm® delivery platform to optimize the delivery for certain indications. The other will explore the application of a known anti-seizure API to treat adult and pediatric patients who suffer from its debilitating effects. As part of our recently announced psychedelic and antiviral clinical development, these programs are exciting because they leverage existing safety and toxicity data. We believe this will allow us to more quickly develop orally bioavailable treatments and expand our specialty pharmaceutical pipeline. We look forward to talking with shareholders in more detail at our H.C. Wainwright investor presentation on June 17.
“Additionally, our wellness subsidiary, Sera Labs, expanded its marketing strategy by launching a national TV, radio and digital marketing campaign in support of accelerating sales for our Sleep A.S.A.P. Nutri-Strips products. Investments in sales & marketing strategies did contribute to a larger net loss for the quarter, but we believe the investment will results in faster growth in these new product lines,” stated Davidson.
About CURE Pharmaceutical Holding Corp.
CURE Pharmaceutical® is the pioneering developer of CUREform™, a patented drug delivery platform that offers a number of unique immediate- and controlled-release drug delivery vehicles designed to improve drug efficacy, safety, and patient experience for a wide range of active ingredients. As a vertically integrated company, CURE’s 25,000 square foot, FDA-registered, NSF® cGMP-certified manufacturing facility enables it to partner with pharmaceutical and wellness companies worldwide for private and white-labeled production. CURE has partnerships in the U.S., China, Mexico, Canada, Israel, and other markets in Europe.
Forward Looking Statement
Statements CURE makes in this press release may include statements which are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended (“Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (“Exchange Act”), which are usually identified by the use of words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “seeks,” “should,” “will,” and variations of such words or similar expressions. CURE intends these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Exchange Act and is making this statement for purposes of complying with those safe harbor provisions. These forward-looking statements include, without limitation, the ability to successfully market the partnered products, the difficulty in predicting the timing or outcome of related research and development efforts, partnered product characteristics and indications, marketing approvals and launches of other products, the impact of pharmaceutical industry regulation, the impact of competitive products and pricing, the acceptance and demand of new pharmaceutical products, the impact of patents and other proprietary rights held by competitors and other third parties and the ability to obtain financing on favorable terms. The forward-looking statements in this press release reflect CURE’s judgment as of the date of this press release. CURE disclaims any intent or obligation to update these forward-looking statements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of our securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210517005365/en/
$RKFL Banknote World Chooses RocketFuel to Power Online Purchases Using Crypto and Bank Transfers
https://finance.yahoo.com/news/banknote-world-chooses-rocketfuel-power-120000120.html?.tsrc=rss
-OXIHF - It is .003 and growing hemp in Florida, with stores also- OXIHF website-PioneerGreenUSA.com -
float is 155 million according to OTC Markets website
$SBFM: Sunshine Biopharma Discusses the Progress of Its COVID-19 and Anticancer Compounds with The Stock Day Podcast
Click here:
https://www.newsfilecorp.com/release/74719/Sunshine-Biopharma-Discusses-the-Progress-of-Its-COVID19-and-Anticancer-Compounds-with-The-Stock-Day-Podcast
About Sunshine Biopharma
In addition, to working on the development of a treatment for COVID-19, Sunshine Biopharma is engaged in the development Adva-27a, a unique anticancer compound. Tests conducted to date have demonstrated the effectiveness of Adva-27a at destroying Multidrug Resistant Cancer Cells, including Pancreatic Cancer cells, Small-Cell Lung Cancer cells, Breast Cancer cells, and Uterine Sarcoma cells. Clinical trials for Pancreatic Cancer indication are planned to be conducted at McGill University's Jewish General Hospital in Montreal, Canada. Sunshine Biopharma is owner of all patents and intellectual property pertaining to Adva-27a.
$EVLI - https://www.everlertinc.com/
"Get Ready... Something Really Cool Is Coming Soon" ... this one is starting to wake up, updated website is indication of a big move coming.
$DKMR Xtreme Fighting Championships Partnered With Europe's Leader In Combat Sports Distribution To Expand Its Global Reach
Click here:
https://www.marketwatch.com/press-release/xtreme-fighting-championships-partners-with-europes-leader-in-combat-sports-distribution-to-expand-its-global-reach-2020-12-03?reflink=mw_share_twitter
Xtreme Fighting Championships, Inc. (formerly Duke Mountain Resources, Inc.) is the first publicly traded premier international mixed martial arts ("MMA") organization with offices throughout the United States and South America, trading under the ticker symbol DKMR. Xtreme Fighting Championships ("XFC") is now partnered with NBC Sports in the United States, and has previously been carried on some of the largest open television broadcasters in Latin America - Rede TV! as well as HBO, ESPN, Esportes Interativo, Terra TV (the largest internet portal in the world), and UOL - the largest internet portal in Latin America, and premium cable & satellite television network. The XFC has had over 185 exclusively signed fighters, representing over 35+ countries worldwide with even more growth expected. Boasting the signing of The Next Generation of Male & Female Superstars, the XFC is known for entertaining fans with the most action packed MMA events both on television and in stadium venues. The Next Generation of MMA.
$GTVH Golden Triangle Ventures, Inc. Announces a Live Q&A Session with CEO
Click here:
https://www.accesswire.com/625040/Golden-Triangle-Ventures-Inc-Announces-a-Live-QA-Session-with-CEO
$NGTF -News on new efforts to showcase the great benefits of the very popular Nightfood ice cream line:
Nightfood Unveils New Packaging with Increased Emphasis on Sleep-Friendly Benefits and Nighttime Nutritional Profile
Tarrytown, NY, Dec. 09, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nightfood, Inc. (OTCQB: NGTF), the company pioneering the category of better-for-you nighttime snacks formulated for better sleep, today provided the public this first look at the brand’s new packaging:
Nightfood sleep-friendly ice cream: Cold Brew Decaf
Nightfood Cold Brew Decaf
Nightfood Full Product Line
The updated packaging features Nightfood’s familiar Cravemonsters™ in a bold new design. All flavors share a new deep blue background for stronger shelf-presence while delivering additional nighttime cues to the consumer.
Most importantly, the front panel is now singularly focused on communicating the brand’s unique point of differentiation and key consumer benefit: Nightfood’s “sleep-friendly” nutritional profile.
“Nightfood was created specifically by our sleep experts with ingredients for better sleep,” stated Nightfood CEO Sean Folkson. “Today’s supermarket shopper is more rushed and distracted than ever, especially with COVID. A brand needs to drive home one thing in the first millisecond the consumer sees that pack. Now our key benefit, captured in the phrase ‘Sleep-Friendly’, is literally front and center on every pint of Nightfood.”
Nightfood coined the phrase “sleep-friendly” to describe snacks formulated with a focus on delivering the nutritional foundation for a better night of sleep. Some of the sleep-friendly characteristics of Nightfood ice cream include more prebiotic fiber, casein protein, calcium, magnesium, and zinc when compared to regular ice cream, as well as less sugar, less fat, and fewer calories. These attributes are called out in detail on the back of each pint.
The packaging updates were made based on information gathered during Nightfood’s first eighteen months on shelf in major supermarkets. During that time, the Company has sold hundreds of thousands of pints, collected thousands of consumer reviews, and conducted in-depth interviews with heavy users and early adopters.
“The feedback on the new packaging from our category managers has been strong,” added Jenny Mitchell, Nightfood’s COO. “And 95% of our consumer reviews are 4 and 5 stars. We believe the new packaging will help consumers further understand the benefits Nightfood delivers, resulting in meaningful increases in both consumer trial and repeat purchase.”
The Nightfood packaging update was executed by OffWhite Co., the design firm behind the iconic packaging designs of Chobani and Maple Hill Creamery. Their work with Chobani helped drive sales from $30 million to crossing the billion-dollar mark in under 4 years, becoming the #1 yogurt brand.
“The team at OffWhite did an amazing job taking our new consumer insights and turning out a final product that can do our selling for us right from the shelf,” added Folkson. “For anybody eating ice cream at night, which is when most pint ice cream is consumed, seeing ‘sleep-friendly’ is sure to stop that consumer in their tracks.”
Production of Nightfood pints in the new packaging is expected to begin in late January. The updated packaging should begin appearing on shelf in both new and existing accounts no later than March.
About Nightfood Holdings:
Nightfood Holdings, Inc. (OTC: NGTF), owns Nightfood, Inc. and MJ Munchies, Inc.
Nightfood has expanded distribution for its ice cream into major divisions of the largest supermarket chains in the United States: Kroger (Harris Teeter), Albertsons Companies (Jewel-Osco and Shaw’s and Star Markets), and H-E-B (Central Market) as well as Lowe’s Foods, Rouses Markets, and other independent retailers.
Nightfood won the 2019 Product of the Year award in the ice cream category in a Kantar survey of over 40,000 consumers. Nightfood was also named Best New Ice Cream in the 2019 World Dairy Innovation Awards.
Nightfood has been endorsed as the Official Ice Cream of the American Pregnancy Association and is the recommended ice cream for pregnant women. There are approximately 3,000,000 pregnant women in the United States at any given time, and ice cream is the single most-widely reported pregnancy craving. With more calcium, magnesium, zinc, prebiotic fiber, and casein protein, less sugar and a lower glycemic profile than regular ice cream, Nightfood has been identified as a better choice for expectant mothers.
Nightfood is not just for pregnant women. Over 80% of Americans snack regularly at night, resulting in an estimated 700M+ nighttime snack occasions weekly, and an annual spend on night snacks of over $50 billion dollars, the majority of it on options that are understood to be both unhealthy, and disruptive to sleep quality.
Nightfood was formulated by sleep and nutrition experts with ingredients that research suggests can support nighttime relaxation and better sleep quality. Scientific research indicates unhealthy nighttime cravings are driven by human biology. Willpower is also weakest at night, and stress is another contributing factor. A majority of night snackers report feeling both guilty and out-of-control when it comes to their nighttime snacking.
Because unhealthy night snacking is believed to be biologically driven, and not a trend or a fad, management sees significant opportunity in pioneering the category of nighttime-specific snacks for better sleep.
MJ Munchies, Inc. was formed in 2018 as a new, wholly owned subsidiary of Nightfood Holdings, Inc. to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company is seeking licensing opportunities to market such products under the brand name “Half-Baked”, for which they’ve successfully secured trademark rights.
Questions can be directed to investors@Nightfood.com
Management also encourages Nightfood shareholders to connect with the Company via these methods:
E-mail: By signing up at ir.nightfood.com, investors can receive updates of filings and news releases in their inbox.
Telegram: There is now a live, interactive Telegram group which interested parties can join to reach team members and discuss Nightfood. Ask questions, learn more about the company and discuss future prospects. Join the Telegram Group Here: https://t.me/NightfoodHoldings
YouTube: The company has established a new YouTube series which will feature weekly videos with team members, insights into latest industry developments, and provide a behind the scenes look at the latest company developments. Click here to subscribe to Nightfood’s YouTube channel.
Forward Looking Statements:
This current press release contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, any products sold or cash flow from operations.
Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with distribution and difficulties associated with obtaining financing on acceptable terms. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our most recent annual report for our last fiscal year, our quarterly reports, and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
Media Contact:
Tim Sullivan
media@Nightfood.com
732-816-0239
Investor Contact:
Stuart Smith
investors@Nightfood.com
888-888-6444, x3
$BBIG on alert! Oversold chart with RSI at 45 >>
About Vinco Ventures, Inc.
Vinco Ventures, Inc. (BBIG) is a mergers and acquisition company focused on digital commerce and consumer brands. Vinco’s B.I.G. (Buy. Innovate. Grow.) strategy will seek out acquisition opportunities that are poised for scale and grow said acquisitions through targeted traffic and content campaigns. For more information, please view our investor presentation or visit Investors.vincoventures.com.
$BTDG - Penny Stocks on the Move: Marketwatch on B2Digital
Click here:
https://www.marketwatch.com/press-release/penny-stocks-on-the-move-otc-us-mcoa-otc-us-cbdd-otc-us-btdg-otc-us-rscf-2020-12-11?reflink=mw_share_twitter
$BTDG is demonstrating growth and success in both major segments of its business plan focused on MMA sports entertainment and the personal fitness sector. This is just the beginning.
B2Digital Reports 126% Q/Q Topline Growth, Projects Current Quarter Acceleration, Major Expansion in Fitness Facility Strategy
Tampa, FL, Dec. 03, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- B2Digital Incorporated (the “Company” or “B2Digital”) (OTCMKTS:BTDG), the premier development league for mixed martial arts (“MMA”), is excited to update shareholders on the Company’s outlook and the accelerating organic and strategic growth underway in its Gym segment, as well as its performance related to this strategy during the three months ended September 30, 2020, and its expectations for related performance during the current quarter ending December 31, 2020, and beyond.
Note that projections and guidance outlined below assume an absence of further regulatory lockdowns related to Covid-19 as well as the widespread distribution of a safe and effective vaccine during 2021.
“Based on the strategy we have in place – and the assumption that we don’t see major new pandemic-related shutdowns that impact the business – we are targeting $4-5 million on the topline over the rolling forward next twelve months,” commented Greg P. Bell, CEO of B2Digital. “This is based on the growth we are seeing now and the continued successful implementation of the company’s roll-up strategy in our Fitness Facility segment, which is the real breadwinner in our broad vision. We are already on pace to more than double the topline on a sequential quarterly basis into year-end.”
During the three months ended September 30, 2020, B2Digital saw a 76% jump in Gym revenues on a sequential quarterly basis. In addition, the Company increased overall revenues across segments totaling topline growth on a sequential quarterly basis during the quarter of 126%. Management also notes that, based on performance thus far and an assumption of no new pandemic-related shutdowns relevant to its current fitness facility operations, it projects a pace to achieve double the top line revenue in Q3 compared to Q2 of this year for the three months ending December 31, 2020.
In addition, the Company plans to continue its roll-up strategy in the fitness facility market over the coming twelve months. The Company’s objective is to acquire one to two new gym facilities every quarter with our goal to increase these acquisitions as the spread of Covid-19 decreases nationally. Thus far, each acquisition the Company makes in the fitness facility space is believed to represent at least $400K per year in rolling forward next twelve-month revenues based on past historical performance.
At this pace, given current metrics and assumptions, including no major return of mandated pandemic-related shutdowns relevant to its current fitness facilities, the Fitness Facility segment could achieve just shy of $4 million in revenues over the rolling forward next twelve months if the company’s acquisition objectives are executed as planned. Paired with a conservative assumption of $75K - $100K in monthly revenues from its live MMA events, encompassing 3 planned fights a month at current revenue achievement rates per fight, the Company believes it has the potential to achieve total revenues of at least $4 to $5 million over the rolling forward twelve months.
“Each acquisition we make in the Fitness Facility space is boosted by our established brand identity as a leader in the MMA space, which is supported by our positioning and our highly visible PPV events as the top development league in mixed martial arts,” continued Bell. “Thus far, we have demonstrated a capacity to locate and capitalize on undervalued assets in the fitness facility space, amplifying performance in these assets when we bring them on board. Our broad vision includes a process of expansion on a regional and eventually national basis, driving value through association with our strong and growing brand. So far, our metrics over recent months unambiguously support this thesis.”
About B2Digital Inc.
With extensive background in entertainment, television, video, and technology, B2Digital (OTC: BTDG) is now forging ahead and becoming a full-service live event sports company. Capitalizing on the combination of B2Digital CEO Greg P. Bell’s expertise and involvement with more than 40,000 live events over his career for major sports leagues and entertainment venues, B2Digital is in the process of developing and acquiring MMA and sports-related companies to build an integrated Premier Development League, Expand the B2 Official Training Facility Program Network and Continue the growth of the B2 Social Media Network for the multibillion-dollar mixed martial arts (“MMA”) industry.
B2Digital intends to create and develop league champions that will move on to the MMA major leagues from the Company’s B2 Fighting Series brand. Each year, the top fighters will be invited to the annual B2 Fighting Series National Championship live event.
B2Digital has developed and deployed the systems and technologies for the operation of the B2 Fighting Series, “B2FS”. This includes social media marketing, event management, digital ticketing sales, digital video distribution, digital marketing, PPV, FTV (Free to View), merchandise sales, brand management and financial control systems. B2Digital owns all rights for TV, internet, social media, media, merchandising and trademarks, and branding for the B2Digital companies.
For more information about B2Digital, visit the Company’s website at www.b2digitalotc.com.
B2Digital has a growing social media presence. Follow us on:
Twitter: @B2digitalOTC
Facebook: https://m.facebook.com/b2digitalotc/
B2Digital: MMA’s Premier Development League
http://www.b